Tybriva Capsule
Prescription Required
Product introduction
Tybriva Capsule is used in the treatment of mantle-cell lymphoma and blood cancer (chronic lymphocytic leukemia). It is also used in chronic lymphocytic leukaemia who have received at least one prior therapy.
It is an anti-cancer medicine.
It is an anti-cancer medicine.
Uses of Tybriva Capsule
Side effects of Tybriva Capsule
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Tybriva
- Headache
- Fever
- Diarrhea
- Stomatitis (Inflammation of the mouth)
- Nausea
- Low blood platelets
- Decreased white blood cell count (neutrophils)
- Fatigue
- Musculoskeletal (bone, muscle or joint) pain
- Rash
- Anemia (low number of red blood cells)
- Bruising
- Muscle spasm
- Hemorrhage
- Pneumonia
- Cough
- Dry eye
- High blood pressure
- Weight loss
- Urinary tract infection
- Peripheral edema
- Subdural hematoma
- Second primary malignancies
How to use Tybriva Capsule
Take this medicine in the dose and duration as advised by your doctor. Tybriva Capsule may be taken with or without food, but it is better to take it at a fixed time.
Safety advice
Alcohol
CONSULT YOUR DOCTOR
It is not known whether it is safe to consume alcohol with Tybriva Capsule. Please consult your doctor.
Pregnancy
CONSULT YOUR DOCTOR
Tybriva Capsule is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
Breast feeding
CAUTION
Tybriva Capsule should be used with caution during breastfeeding. Breastfeeding should be held until the treatment of the mother is completed and the drug is eliminated from her body.
Driving
UNSAFE
Tybriva Capsule may cause side effects which could affect your ability to drive.
Kidney
CAUTION
Tybriva Capsule should be used with caution in patients with kidney disease. Dose adjustment of Tybriva Capsule may be needed. Please consult your doctor.
Liver
CAUTION
Tybriva Capsule should be used with caution in patients with liver disease. Dose adjustment of Tybriva Capsule may be needed. Please consult your doctor.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
Tybriva Capsule
₹350.0/Capsule
Ibronza 140mg Capsule
Sun Pharmaceutical Industries Ltd
₹257.97/capsule
26% cheaper
₹3270/capsule
834% costlier
Ibrushil 140mg Capsule
Shilpa Medicare Ltd
₹290.99/capsule
17% cheaper
IB-Tib Capsule
Cadila Pharmaceuticals Ltd
₹263.3/capsule
25% cheaper
Nitib 140mg Capsule
Hetero Healthcare Limited
₹323.33/capsule
8% cheaper
Quick tips
- Take it at the same time every day, either with or without food.
- It is advisable to stay hydrated and drink plenty of fluids while taking this medication.
- Do not skip any dose and complete the course as suggested by your doctor.
- Use an effective method of birth control to avoid pregnancy while taking this medication.
- Your doctor may get regular blood tests done to monitor your liver function and blood cell count in your blood.
Fact Box
Chemical Class
Diphenylethers Derivative
Habit Forming
No
Therapeutic Class
ANTI NEOPLASTICS
Action Class
Bruton's tyrosine kinase (BTK) inhibitors
Patient concerns
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Central Drugs Standard Control Organisation (CDSCO). [Accessed 27 Mar. 2019] (online) Available from:
- Ibrutinib. Beerse Belgium: Janssen Pharmaceutica NV; [Accessed on 27 Mar. 2019] (online) Available from:
Marketer details
Name: Emcure Pharmaceuticals Ltd
Address: 255/2, Hinjawadi, Pune - 411057, India
Country of origin: India
Lab tests offered by us
Related/Popular tests
58 people viewed this recentlyMRP
₹10500
Inclusive of all taxes
30.0 capsules in 1 bottle
SOLD OUT
Notify me